Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
about
Treatment options for localized prostate cancerFocal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literatureThe rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data BaseIs robotic arm stereotactic body radiation therapy “virtual high dose ratebrachytherapy” for prostate cancer? An analysis of comparative effectiveness using published data [corrected].Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [68Ga]PSMA I&T and comparison with published data of [68Ga]PSMA HBED-CC.Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy.Promise and pitfalls of heavy-particle therapy.Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer - between options.MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer.Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil.Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer.Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment.Impact of post-implant dosimetric parameters on the quality of life of patients treated with low-dose rate brachytherapy for localised prostate cancer: results of a single-institution study.Comparison of biochemical recurrence in prostate cancer patients treated with radical prostatectomy or radiotherapy.Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study.Prostate cancer brachytherapy: guidelines overview.The impact of trainee involvement on outcomes in low-dose-rate brachytherapy for prostate cancer.Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database.A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.Oncologic Outcome of Radical Prostatectomy as Monotherapy for Men with High-risk Prostate Cancer.Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.Racial and socioeconomic disparities in the selection of prostate brachytherapyUtilization of prostate brachytherapy for low risk prostate cancer: Is the decline overstated?Advances in androgen receptor targeted therapy for prostate cancerProstate Cancer Radiation Therapy: What Do Clinicians Have to Know?Comparative cost-effectiveness of focal and total salvage 125I brachytherapy for recurrent prostate cancer after primary radiotherapy.Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer.Brachytherapy: where has it gone?Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy.MicroRNAs as putative mediators of treatment response in prostate cancer.Defining a dose-response relationship for prostate external beam radiotherapy.Radical prostatectomy versus high dose permanent prostate brachytherapy using iodine-125 seeds for patients with high risk prostate cancer: a matched cohort analysis.Canadian prostate brachytherapy in 2012.Evolution of advanced technologies in prostate cancer radiotherapy.Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer.Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy.FROGG high-risk prostate cancer workshop: patterns of practice and literature review: part I: intact prostate.
P2860
Q26825653-577AE10A-E50C-4FF6-ACEA-EFD8383B336CQ28828469-2129ED16-8E93-4190-A4B5-9DBA3FAF0806Q30802068-581194C3-9FCF-48F1-9F7E-54552F06B420Q30881854-4B77C2E3-21B0-4539-BC37-6394790DA1B9Q31145236-5E28C99A-B89D-43EE-BEAC-9E1C961B053AQ33918003-04987F67-C606-4418-8359-62BE5994588BQ34124263-79351A13-11AE-4173-8D04-28F25071277CQ34342191-3FF900E1-3465-43A1-AD82-7DB5FC597C08Q34381328-8B347DD3-11FC-4A90-845E-491B0BF7FF63Q34988813-244242E4-A8BC-4DEF-996D-54E8378FEEF9Q35079338-BEF35AA7-7C5D-419A-96C0-1BE1F2F11CEAQ35166901-0ED4C9E1-E438-465A-8065-BFCDBAFEE597Q35582296-29D69702-9100-4217-A05B-3FAACC6848CEQ35730096-5DEE310C-CB07-4F72-BCEF-EA614B8D8297Q36177114-4B91B599-CDD1-4C10-8860-3CB4C263BAA6Q36292667-6BAFC004-9782-4118-B36B-C4DD53D54442Q36555616-03850FC1-68FF-4B69-B355-31CB70E36B53Q36680127-B67E0A9A-A682-427F-BEFF-4BADE23AA187Q36720411-5F08A9AC-AA63-4176-96B9-EAE668454CFCQ36740528-3494D1B8-FED6-478E-9D92-93FD58A4FF08Q37014814-F77A485B-1CB7-477B-9D65-5119D49D8643Q37209369-D455DFC2-7B49-4402-9513-C6BCAF8F5850Q37231596-BC01A45B-6BDB-411E-84C1-2B788624B0C3Q37246911-C3B106D3-0782-4E1B-B00D-B124F92C1BACQ37337217-1AC7E74E-CA1C-415A-968D-C3B918074227Q37578562-71D95F94-A668-4188-B01F-24F916E3E327Q37590695-E2744341-D81E-4C51-8331-545807A1E361Q37605565-FBC57F13-1132-4EC4-8D83-6757070C504EQ37631572-20843770-B735-4B07-8A98-F3F0D27D0051Q37658906-922679B9-450F-491D-83A1-B395458D04BEQ37676065-D07E8D23-C54C-4917-B2CB-88D808AFB272Q38011943-F18F8EFA-17AB-4564-9E9C-915D6C0AA9EDQ38095668-D9D90768-B3FD-438A-A9A3-9D41391FC567Q38102550-4D15E5F8-699B-4147-BC62-C99532065672Q38106699-303F96B2-82AB-4EC0-82DF-C44D0B70DF84Q38135708-885A6E1C-F907-4B31-A941-46A30E0ABD64Q38152466-785D9121-54A8-4AE5-8ED2-8DE0E08E1540Q38160244-00E494EB-44A7-482B-ACA1-AC1B4F10457FQ38162632-96927315-EA43-4946-AD90-BC430F741955Q38168635-5DE28BE0-55F5-4B25-8040-FA24A5BCD8C4
P2860
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Comparative analysis of prosta ...... ate Cancer Results Study Group
@ast
Comparative analysis of prosta ...... ate Cancer Results Study Group
@en
Comparative analysis of prosta ...... ate Cancer Results Study Group
@nl
type
label
Comparative analysis of prosta ...... ate Cancer Results Study Group
@ast
Comparative analysis of prosta ...... ate Cancer Results Study Group
@en
Comparative analysis of prosta ...... ate Cancer Results Study Group
@nl
prefLabel
Comparative analysis of prosta ...... ate Cancer Results Study Group
@ast
Comparative analysis of prosta ...... ate Cancer Results Study Group
@en
Comparative analysis of prosta ...... ate Cancer Results Study Group
@nl
P2093
P2860
P50
P3181
P1433
P1476
Comparative analysis of prosta ...... ate Cancer Results Study Group
@en
P2093
Anthony Zietman
Brian J Moran
David Bostwick
Gregory Merrick
Ignace Billiet
Jason Wong
Jos Immerzeel
Jyoti Mayadev
Katsuto Shinohara
P2860
P3181
P356
10.1111/J.1464-410X.2011.10827.X
P407
P478
109 Suppl 1
P577
2012-02-01T00:00:00Z